Market News AIOpen the app

Lisata Therapeutics said it had no sales and a bigger loss of $10.03 million last quarter.

ResultsRead the original at moomoo.com
Bad for LSTA

Lisata's revenue stayed at $0, matching last year, but its operating loss grew from $4.41 million to $10.03 million. The larger loss makes this report unfavorable.

LSTA · Lisata Therapeutics

AI read · Bad for LSTA

The AI's read

The unchanged sales figure offers no improvement, and the larger operating loss shows Lisata lost more from its operations. The worsening loss per share points in the same direction. Together, these figures make the report unfavorable for Lisata.

Get alerts for LSTA

Follow Lisata Therapeutics (LSTA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LSTA
Free on the App Store and Google Play, or on the web.